City State Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.3K Buy
+22
New +$4.82K ﹤0.01% 640
2025
Q4
Sell
-2
Closed -$264 777
2025
Q3
$264 Hold
2
﹤0.01% 720
2025
Q2
$212 Hold
2
﹤0.01% 728
2025
Q1
$248 Hold
2
﹤0.01% 726
2024
Q4
$246 Hold
2
﹤0.01% 703
2024
Q3
$223 Hold
2
﹤0.01% 714
2024
Q2
$213 Buy
+2
New +$220 ﹤0.01% 705
2022
Q4
Sell
-2
Closed 679
2022
Q3
$0 Hold
2
﹤0.01% 685
2022
Q2
$0 Buy
+2
New +$308 ﹤0.01% 688

Other funds holding JAZZ

City State Bank's JAZZ Position: Q2 2026 in Review

City State Bank opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 22 shares worth $5.3K. The stake represents ﹤0.01% of the portfolio and ranks #640 among its holdings. This is a return to the name: City State Bank previously reported a position in JAZZ as recently as Q3 2025.

City State Bank first reported a position in JAZZ in Q2 2022 and has held it in 9 quarters since. 202 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • City State Bank held 22 shares of Jazz Pharmaceuticals worth $5.3K as of Q2 2026.
  • Jazz Pharmaceuticals was a new City State Bank position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of City State Bank's portfolio in Q2 2026, its #640 holding.
  • City State Bank first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 9 quarters since.
  • 202 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.